Abstract

Objectives: this study investigates the identification of bacteria that cause urinary tract infections (UTIs) in order to evaluate their resistance to multiple drugs (MDR) and the occurrence of C-reactive protein in UTIs during pregnancy. Methods: in this study, analyzed urine and blood samples from 120 pregnant women in Al Samawa City to identify bacteria causing urinary tract infections (UTIs) during pregnancy. Escherichia coli is the most common pathogenic bacterium, responsible for UTIs connected to pregnancy. C-reactive protein is a highly responsive protein that is used to detect infectious or inflammatory disorders. Results: out of the total sample, 102 (85 %) were positive for different types of bacteria, including Escherichia coli, Staphylococcus aureus, Enterococcus faecalis, Coagulase negative staphylococci, Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus mirabilis, Enterobacter cloacae complex, Kocuria rhizophila, Staphylococcus epidermidis, and Staphylococcus saprophyticus. Conclusion: the study found that nitrofurantoin is effective against both gram-positive and gram-negative bacteria, while cephalexin is ineffective against them. This study recorded the highest CRP concentration above normal range in pregnant women infected with K. pneumonia, followed by pregnant women infected with P. aeruginosa and E. faecalis, in contrast lowest CRP within normal range in non-pregnant women 44 specimens (control), at p. value < 0,05

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.